109 related articles for article (PubMed ID: 1308047)
1. The effect of a cholecystokinin receptor antagonist lorglumid on the proteinase-antiproteinase balance in taurocholate acute experimental pancreatitis (AEP) in rats.
Kosidło S; Rydzewska G; Gabryelewicz A
Mater Med Pol; 1992; 24(4):223-6. PubMed ID: 1308047
[TBL] [Abstract][Full Text] [Related]
2. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
3. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats.
Gabryelewicz A; Kosidlo S; Prokopowicz J; Podkowicz K
Hepatogastroenterology; 1986 Apr; 33(2):79-82. PubMed ID: 2424815
[TBL] [Abstract][Full Text] [Related]
4. Role of endogenous cholecystokinin in the regeneration of pancreatic tissue after acute hemorrhagic pancreatitis in rats.
Song W; Yamaguchi H; Nakano I; Kimura T; Nawata H
Fukuoka Igaku Zasshi; 1996 Jan; 87(1):14-22. PubMed ID: 8820983
[TBL] [Abstract][Full Text] [Related]
5. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats.
Kruse P; Lasson A; Hage E
J Surg Res; 1999 Aug; 85(2):294-300. PubMed ID: 10423332
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis.
Latorre M; Bartolomé-Nebreda JM; García-López MT; González-Muñiz R; Herranz R; Del Río J; Cenarruzabeitia E
Pharmacology; 2004 Oct; 72(2):68-76. PubMed ID: 15331911
[TBL] [Abstract][Full Text] [Related]
7. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models.
Tani S; Okabayashi Y; Nakamura T; Fujii M; Itoh H; Otsuki M
Pancreas; 1990 May; 5(3):284-90. PubMed ID: 2343042
[TBL] [Abstract][Full Text] [Related]
8. Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade.
Niederau C; Borchard F; Lüthen R; Niederau M
Hepatogastroenterology; 1996; 43(12):1442-53. PubMed ID: 8975946
[TBL] [Abstract][Full Text] [Related]
9. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats.
Papp M; Varga G; Folly G
Acta Physiol Hung; 1991; 78(1):61-7. PubMed ID: 1722380
[TBL] [Abstract][Full Text] [Related]
10. Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats.
Jia D; Yamamoto M; Otsuki M
World J Gastroenterol; 2015 Jul; 21(25):7742-53. PubMed ID: 26167074
[TBL] [Abstract][Full Text] [Related]
11. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats.
Yagci G; Gul H; Simsek A; Buyukdogan V; Onguru O; Zeybek N; Aydin A; Balkan M; Yildiz O; Sen D
J Gastroenterol; 2004; 39(3):268-76. PubMed ID: 15065005
[TBL] [Abstract][Full Text] [Related]
13. Possible role of cholecystokinin in the development of acute pancreatitis in rats.
Shinya H; Fujimura M
Nihon Geka Hokan; 1989 Jan; 58(1):3-17. PubMed ID: 2802913
[TBL] [Abstract][Full Text] [Related]
14. Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats.
Kruse P; Hage E; Lasson A
Int J Pancreatol; 1999 Apr; 25(2):113-21. PubMed ID: 10360224
[TBL] [Abstract][Full Text] [Related]
15. Cytokine level changes in L-arginine-induced acute pancreatitis in rat.
Takács T; Czakó L; Jármay K; Farkas G; Mándi Y; Lonovics J
Acta Physiol Hung; 1996; 84(2):147-56. PubMed ID: 9046361
[TBL] [Abstract][Full Text] [Related]
16. The effect of antecedent acute ethanol ingestion on the pancreas ultrastructure in taurocholate pancreatitis in rats.
Andrzejewska A; Dlugosz JW; Jurkowska G
Exp Mol Pathol; 1998 Oct; 65(2):64-77. PubMed ID: 9828148
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats.
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
Pancreas; 1998 Oct; 17(3):289-94. PubMed ID: 9788544
[TBL] [Abstract][Full Text] [Related]
18. [Protective effect of pancreatic enzyme depletion in the course of acute pancreatitis--experimental study in rats].
Coelho AM; Kubrusly MS; Bonizzia A; Gonçalez Y; Abdo EE; Machado MC
Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(3):106-11. PubMed ID: 8248698
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin blockade triggers earlier and enhanced intra-acinar oxygen free radical generation in acute pancreatitis induced by pancreatic duct obstruction in rats.
Uruñuela A; Manso MA; de la Mano AM; de Dios I
Clin Sci (Lond); 2003 Aug; 105(2):203-12. PubMed ID: 12713440
[TBL] [Abstract][Full Text] [Related]
20. Experimental acute necrotising pancreatitis: evaluation and characterisation of a model of intraparenchymal injection of sodium taurocholate in rats.
Paran H; Mayo A; Kidron D; Sivak G; Reshef T; Vider T; Ziv O; Freund U
Eur J Surg; 2000 Nov; 166(11):894-8. PubMed ID: 11097158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
